Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
06/2000
06/15/2000WO2000034334A1 DNA ENCODING A MAMMALIAN RECEPTOR (fb41a) AND USES THEREOF
06/15/2000WO2000034332A1 Glp-1 analogues
06/15/2000WO2000034331A2 Analogues of glp-1
06/15/2000WO2000034284A1 2,5-diazabicyclo[2.2.1]heptane derivatives, their preparation and therapeutic uses
06/15/2000WO2000034280A1 4-oxoimidazolidine-2-spiro-nitrogenous heterocycle compounds
06/15/2000WO2000034279A1 1,4-diazabicyclo[3.2.2]nonane derivatives, their preparation and therapeutic application
06/15/2000WO2000034276A1 Pyridyl-bridgehead derivatives and their analogues, pharmaceutical compositions and their use as inhibitors of nicotinic cholinergic receptors
06/15/2000WO2000034266A1 Indole derivatives and their use as 5-ht1f agonists
06/15/2000WO2000034263A1 Benzofuran derivatives, their preparation and use
06/15/2000WO2000034262A1 Benzofuran derivatives, process for the preparation of the same and uses thereof
06/15/2000WO2000034258A2 Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group
06/15/2000WO2000034250A1 2,4-dioxo-5-arylidenimino-1,3-pyrimidines
06/15/2000WO2000034248A1 New benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents
06/15/2000WO2000034244A1 3-substituted-4-arylquinolin-2-one derivatives as potassium channel modulators
06/15/2000WO2000034243A1 N-(2-phenyl-4-piperidinybutyl)-5,6,7,8-tetrahydro-1-naphthalenecarboxamides and their use as neurokinin 1 (nk1) and/or neurokinin 2 (nk2) receptor antagonists
06/15/2000WO2000034236A1 REVERSIBLE AQUEOUS pH SENSITIVE LIPIDIZING REAGENTS, COMPOSITIONS AND METHODS OF USE
06/15/2000WO2000034228A1 Ion channel modulating agents
06/15/2000WO2000033880A2 Conjugate used for enriching in neuronal cells
06/15/2000WO2000033864A1 Remedies for tactile failures
06/15/2000WO2000033862A1 Self-emulsifying compositions for drugs poorly soluble in water
06/15/2000WO2000033843A1 Use of long-chain n-alkyl derivatives of deoxynojirimycin for the manufacture of a medicament for the treatment of glycolipid storage diseases
06/15/2000WO2000033835A1 Controlled-release dosage forms comprising zolpidem or a salt thereof
06/15/2000WO2000033834A1 Use of isatin derivatives as ion channel activating agents
06/15/2000WO2000033828A1 Agent for lowering endothelin levels
06/15/2000WO2000033814A2 Method for administering agents to the central nervous system
06/15/2000WO2000033813A1 Administration of neurotrophic agents to the central nervous system
06/15/2000WO2000033812A2 Transdermal patch for delivering volatile liquid drugs
06/15/2000WO2000033810A1 Use of vitamin b12 in a nasal composition for delivering active agents to the central nervous system
06/15/2000WO2000013672A9 New solid dose form of nanoparticulate naproxen
06/15/2000WO2000010536A8 Extended release buccal bioadhesive tablet
06/15/2000WO2000009107A3 Sulfonamides of n-containing heterocyclic thioesters for vision and memory disorders
06/15/2000WO2000008192A3 Herpesviral vectors for gene delivery
06/15/2000WO2000008143A3 Gene isolated on the short arm of human chromosome 17
06/15/2000WO2000002546A3 Use of caba-analogues for treating insomnia
06/15/2000WO2000001821A3 Neurotransmission associated proteins
06/15/2000WO1999066051A3 Nek-related and bub1-related protein kinases
06/15/2000WO1999060021A3 Use of activated t cells, nervous system-specific antigens for treating disorders of the nevrous system
06/15/2000WO1999038503A8 Pharmacological uses of optically pure (+)-bupropion
06/15/2000WO1999014328A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/15/2000DE19906977C1 Transdermal patch for administering deoxypeganin, useful for treating dementia-associated cognitive impairment and preventing intoxication by organic thiophosphate esters
06/15/2000DE19857475A1 Substituierte Cycloheptene, deren Herstellung und Verwendung Substituted cycloheptenes, their preparation and use
06/15/2000CA2778047A1 Analogues of glp-1
06/15/2000CA2380391A1 Transdermal patch for delivering volatile liquid drugs
06/15/2000CA2363310A1 2,4-dioxo-5-arylidenimino-1,3-pyrimidines
06/15/2000CA2354644A1 Muc-1 antagonists and methods of treating immune disorders
06/15/2000CA2354233A1 Self-emulsifying compositions for drugs poorly soluble in water
06/15/2000CA2354142A1 Reversible aqueous ph sensitive lipidizing reagents, compositions and methods of use
06/15/2000CA2353797A1 Neuron-associated proteins
06/15/2000CA2353618A1 Benzofuran derivatives, their preparation and use
06/15/2000CA2353616A1 Assays for compounds which increase phospholipase a2 activity
06/15/2000CA2350767A1 Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing phenylenediamine group
06/15/2000CA2349616A1 New benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents
06/15/2000CA2317025A1 Pyridyl-bridgehead derivatives and their analogues, pharmaceutical compositions and their use as inhibitors of nicotinic cholinergic receptors
06/14/2000EP1008594A1 Compounds derived from thophene and benzothiophene, and related utilisation and composition
06/14/2000EP1007714A1 Regulatory sequences capable of conferring expression of a heterologous dna sequence in endothelial cells in vivo and uses thereof
06/14/2000EP1007693A1 Pak kinase genes and polypeptides and methods of use thereof
06/14/2000EP1007666A1 Neurturin receptor
06/14/2000EP1007563A1 Hm74a receptor
06/14/2000EP1007562A1 TUMOR NECROSIS FACTOR RECEPTOR RELATED PROTEINS TANGO-63d AND TANGO-63e
06/14/2000EP1007561A2 Novel conjugates of opioids and endogenous carriers
06/14/2000EP1007539A1 Secreted proteins and polynucleotides encoding them
06/14/2000EP1007534A1 Bh3 interacting domain death agonist
06/14/2000EP1007526A1 Substituted 4-oxo-napthyridine-3-carboxamides as gaba brain receptor ligands
06/14/2000EP1007524A1 Indole derivatives as 5-ht1b and 5-ht1d agonists
06/14/2000EP1007522A1 2- 4-[4-(4, 5-dichloro -2-methylimidazol-1-yl) butyl]-1-piperazinyl -5-fluoropyrimidine,preparation and therapeutic use
06/14/2000EP1007521A1 Compounds possessing neuronal activity
06/14/2000EP1007520A1 2-aminopyridines containing fused ring substituents as nos inhibitors
06/14/2000EP1007514A1 Heterocyclic ketones as npy y5 antagonists
06/14/2000EP1007512A1 Branched alkoxy-subsituted 2-aminopyridines as nos inhibitors
06/14/2000EP1007505A1 Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives
06/14/2000EP1007090A1 Identification of unique binding interactions between certain antibodies and the human b7.1 and b7.2 co-stimulatory antigens
06/14/2000EP1007067A1 Pharmaceutical compositions containing parthenium integrifolium or parts thereof or an extract or component thereof, the use of such plant material for preparing certain medicines, and a method of preparing an extract of parthenium integrifolium
06/14/2000EP1007064A1 Regeneration of nerves in the central nervous system
06/14/2000EP1007062A1 Therapeutic use of hemoglobin to treat head injury
06/14/2000EP1007060A2 Stable extract of hypericum perforatum l., a method for producing the same, and corresponding pharmaceutical preparations
06/14/2000EP1007053A1 Treatment of pain
06/14/2000EP1007050A1 Method for treating substance abuse
06/14/2000EP1007048A1 Identification of agents for use in the treatment of alzheimer's disease
06/14/2000EP1007043A1 Method for treatment of cns-involved lysosomal storage diseases
06/14/2000EP1007041A1 Composition for treating pain
06/14/2000EP1007040A1 Use of phanquinone for the treatment of alzheimer's disease
06/14/2000EP1007024A1 Delayed-release dosage forms of sertraline
06/14/2000EP1006969A1 Intranasal formulations for promoting sleep and method of using the same
06/14/2000EP1006802A1 Chemical and pharmacological standardization of herbal extracts
06/14/2000EP1006801A1 Sertoli cells as neurorecovery inducing cells for neurodegenerative disorders
06/14/2000EP1006794A1 A method for treating or preventing alzheimer's disease
06/14/2000EP0823892B1 Tetralines bearing a phenyl substituant on the aromatic ring and their use in the treatment of epilepsy, stroke and brain or spinal trauma
06/14/2000CN1256629A Therapeutic compositions
06/14/2000CN1256139A Smoking-giving up tea and its preparation
06/14/2000CN1256127A Drinking-stopping medicine
06/14/2000CN1053441C Compound with 1-(aryl china olefine)-4-(aryl methyl) piperazine structure, its preparation process and medicine containing the compound thereof
06/14/2000CN1053438C Benzodiazepin-2-one derivatives, process for their prepn. and pharmaceutical composition containing them
06/14/2000CN1053370C Method for prepn. of Jiyidan pill
06/14/2000CN1053366C Chinese herbal lotion and its prepn.
06/14/2000CN1053365C Nutrient for youngsters
06/14/2000CN1053355C Medicated wine composition for curing sciatica
06/14/2000CN1053346C Refresh medicament and its prepn.
06/14/2000CN1053341C Use of nadh and nadph or their salts in pharmaceutic
06/14/2000CN1053339C Controlled release morphine prepn.
06/13/2000US6075054 Antiarrhythmic pharmaceuticals having a cardioprotective component for infarct prophylaxis and infarct treatment as well as for the treatment of angina pectoris
1 ... 1501 1502 1503 1504 1505 1506 1507 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 ... 1833